Publicaciones en colaboración con investigadores/as de Pitié-Salpêtrière Hospital (28)

2023

  1. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  2. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  3. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  4. European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)

    Neuro-oncology, Vol. 25, Núm. 1, pp. 37-53

2022

  1. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial

    The Lancet Oncology, Vol. 23, Núm. 1, pp. 77-90

2016

  1. Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma

    Cancer Investigation, Vol. 34, Núm. 1, pp. 39-44

  2. The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells

    Immunity, Vol. 45, Núm. 6, pp. 1205-1218

2015

  1. VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab

    Journal of Neuro-Oncology, Vol. 121, Núm. 3, pp. 499-504

2014

  1. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool

    Neuro-Oncology, Vol. 16, Núm. 4, pp. 520-527

  2. Abnormal functional connectivity between motor cortex and pedunculopontine nucleus following chronic dopamine depletion

    Journal of Neurophysiology, Vol. 111, Núm. 2, pp. 434-440

  3. An ANOCEF genomic and transcriptomic microarray study of the response to irinotecan and bevacizumab in recurrent glioblastomas

    BioMed Research International, Vol. 2014

  4. Brain metastases

    Handbook of Clinical Neurology (Elsevier B.V.), pp. 1143-1157

  5. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma

    Cancer, Vol. 120, Núm. 24, pp. 3972-3980

  6. Erratum: Node Accessibility in Cortical Networks During Motor Tasks [Neuroinformatics 11, (2013) 355-366, DOI 10.1007/s12021-013-9185-2]

    Neuroinformatics

  7. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

  8. Management of elderly patients with gliomas

    Oncologist, Vol. 19, Núm. 12, pp. 1258-1267

2013

  1. Node accessibility in cortical networks during motor tasks

    Neuroinformatics, Vol. 11, Núm. 3, pp. 355-366

  2. Remote synchronization reveals network symmetries and functional modules

    Physical Review Letters, Vol. 110, Núm. 17

2012

  1. Community structure in large-scale cortical networks during motor acts

    Chaos, Solitons and Fractals, Vol. 45, Núm. 5, pp. 603-610

  2. Detection of IDH1 mutation in the plasma of patients with glioma

    Neurology, Vol. 79, Núm. 16, pp. 1693-1698